2 авг. 2022 г. · A US appeals court on Monday affirmed that AbbVie Inc did not unlawfully block competition by building up a "thicket" of patents related to its blockbuster ...

7 дек. 2022 г. · AbbVie applied for at least 247 patents, of which 132 were granted, creating a patent thicket that protects Humira from competition until 2037 ( ...

AbbVie applied for approximately 247 patents, of which 132 were granted, creating a “patent thicket” protecting Humira from competition until 2037 (when the ...

17 мар. 2022 г. · At the same time, AbbVie meticulously built a wall of intellectual property — sometimes called a “patent thicket” — around Humira and each new ...

8 авг. 2022 г. · Indirect purchasers of Humira brought a class action against AbbVie in 2019, alleging that the 'thicket' of additional patents and related ...

22 часа назад · Panel A shows the adalimumab (Humira) patent thicket, which includes all the patents used in suits against potential competitors. Each node ...

The city of Baltimore, the largest grocery-worker union in New York and at least four other health plans have filed lawsuits against AbbVie over the past ...

2 сент. 2022 г. · 'Patent Thicket'. For many years Humira was the world's top-selling drug, but the principal US patent expired in 2016. AbbVie obtained an ...

The Humira patent thicket, the Noerr-Pennington doctrine and antitrust's patent problem.

8 мар. 2024 г. · A patent thicket is a number of overlapping patents to protect a single product, in this case, Humira. In fact, AbbVie filed for a whopping 311 ...